Financials in USD. Standardized financial statements.
A compact view of how Addex Therapeutics Ltd turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $29,972 | $404,102 | $1.61M | $1.42M | $2.92M | $3.61M | $2.76M | $6.04M | $499,894 | $17,329 |
| Revenue Growth? | -92.6% | -74.9% | +13.4% | -51.2% | -19.3% | +30.8% | -54.3% | +1109.0% | +2784.7% | 0.0% |
| Cost of Revenue? | $0 | $0 | $0 | $0 | $0 | $0 | $230,097 | $144,169 | $29,764 | $17,329 |
| Gross Profit? | $29,972 | $404,102 | $1.61M | $1.42M | $2.92M | $3.61M | $2.53M | $5.90M | $470,130 | $0 |
| Gross Margin? | +100.0% | +100.0% | +100.0% | +100.0% | +100.0% | +100.0% | +91.7% | +97.6% | +94.0% | 0.0% |
| Operating Expenses? | $2.84M | $3.16M | $3.86M | $11.96M | $18.42M | $15.86M | $17.14M | $7.47M | $3.24M | $3.14M |
| Operating Income? | -$2.81M | -$2.76M | -$2.24M | -$10.54M | -$15.51M | -$12.24M | -$14.60M | -$1.42M | -$3.24M | -$3.13M |
| EBITDA? | -$6.83M | -$4.65M | -$2.19M | -$10.45M | -$14.94M | -$12.41M | -$14.32M | -$1.51M | -$3.22M | -$3.12M |
| Income Before Tax | -$6.84M | -$4.91M | -$2.50M | -$10.80M | -$15.35M | -$12.86M | -$14.78M | -$1.64M | -$3.28M | -$3.15M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $6,924 |
| Net Income? | -$6.73M | $7.06M | -$10.56M | -$20.80M | -$15.35M | -$12.86M | -$14.78M | -$1.64M | -$3.28M | -$3.15M |
| EPS? | $-6.88 | $8.40 | $-16.80 | $-55.20 | $-54.00 | $-57.60 | $-67.20 | $-8.47 | $-30.00 | $-33.60 |
| Diluted EPS? | $-6.88 | $8.40 | $-16.80 | $-55.20 | $-54.00 | $-57.60 | $-67.20 | $-8.47 | $-30.00 | $-33.60 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality